CompletedNCT03630315
CLN-0046: Treatment of AMD Subjects With OTX-TKI
PHASE1 · 29 planned enrolment
- Countries listed
- 1
- Registry update
- July 10, 2024
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
5 matching trial registrations
- Intervention Anti-VEGF
Showing 1–5 of 5. Every record below meets all the filters shown above.
CompletedNCT04626128
Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD
PHASE1 · PHASE2 · 27 planned enrolment
- Countries listed
- 1
- Registry update
- September 18, 2023
CompletedNCT05678517
Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD
Phase not reported · 47 planned enrolment
- Countries listed
- 1
- Registry update
- January 10, 2023
TerminatedNCT02348359
X-82 to Treat Age-related Macular Degeneration
PHASE2 · 157 planned enrolment
- Countries listed
- 1
- Registry update
- February 11, 2022
TerminatedNCT03699618
Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration
Phase not reported · 1 planned enrolment
- Countries listed
- 1
- Registry update
- February 19, 2020